This inventor holds 96 USPTO granted patents and 34 published patent applications, plus 11 CIPO patents and 34 EPO patents, primarily in GLP-1R Modulation (CPC class A61K45-06). Top assignees: Gilead Sciences, Inc., Gilead Pharmasset LLC, Salesforce Com, Inc.. Active years: 1996-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- San Antonio, TX (US) (1996)
- Jacksonville, FL (US) (2012)
- Reddick, FL (US) (2017)
- San Mateo, CA (US) (2013 - 2019)
- Evansville, IN (US) (2020)
- Foster City, CA (US) (2012 - 2023)
- San Francisco, CA (US) (2013 - 2023)
- Sterling, VA (US) (2023)
- Bartlett, IL (US) (2011 - 2024)
- Burlingame, CA (US) (2013 - 2024)
Company Filing History:
54 out of 950 
15 out of 81 
12 out of 3,145 
Years Active: 1996-2026
Areas of Expertise:
Title: Celebrating the Innovations of James G Taylor
Introduction: James G Taylor is a prolific inventor based in Burlingame, California, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 62 patents, Taylor focuses on developing innovative compounds that address critical medical conditions.
Latest Patents: Among Taylor's recent work, he has been granted patents for GLP-1R modulating compounds. These patents describe GLP-1R agonists, along with various compositions, methods, and kits related to these compounds. The applications are particularly focused on treating diseases or conditions mediated by GLP-1R, showcasing Taylor's commitment to addressing pressing health issues through scientific innovation.
Career Highlights: Taylor has had an impactful career with significant roles in renowned companies such as Gilead Sciences, Inc. and Gilead Pharmasset LLC. His work at these organizations has been pivotal in advancing pharmaceutical research and development, particularly in the emerging field of GLP-1R modulation.
Collaborations: Throughout his career, James G Taylor has collaborated with esteemed colleagues, including Jeromy J Cottell and John O Link. These partnerships have further fueled his innovative capabilities, allowing him to share insights and knowledge that enhance their collective research efforts.
Conclusion: James G Taylor exemplifies the spirit of innovation through his extensive work in pharmaceutical inventions. His focus on GLP-1R modulating compounds not only reflects his dedication to scientific advancement but also highlights the importance of collaboration in driving meaningful progress in the medical field. As he continues to push the boundaries of research, Taylor remains a prominent figure in the realm of patents and innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile